tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tiago Fauth, 125 are a BUY (73.53%), 40 are a HOLD (23.53%), 5 are a SELL (2.94%).
Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 42.65% that have a potential upside of 25.71% achieved within 108 days. Previously, Tiago Fauth worked at CREDIT SUISSE.
Tiago Fauth’s has documented 338 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRNA, Verona Pharma PLC ADR at 20-Jun-2025.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$1.39 (38.50%)
$4
2 months 12 days ago
(16-Apr-2025)
0/6 (0%)
$2.61 (109.21%)
Hold
3 months 25 days ago
(03-Mar-2025)
0/2 (0%)
$6.55 (120.18%)
Buy
$5
$1.39 (38.50%)
$22
7 months 23 days ago
(05-Nov-2024)
0/4 (0%)
$2.28 (83.82%)
Buy
$24
$20.39 (564.82%)
$30
1 years 10 months 24 days ago
(04-Aug-2023)
0/2 (0%)
$17.96 (297.35%)
Buy
$28
$24.39 (675.62%)
$34
2 years 1 months 23 days ago
(05-May-2023)
1/6 (16.67%)
$22.01 (367.45%)
24
Which stock is Tiago Fauth is most bullish on?
Which stock is Tiago Fauth is most reserved on?
What Year was the first public recommendation made by Tiago Fauth?
